In vitro and in vivo antifungal activities of T-2307, a novel arylamidine, against Cryptococcus gattii: an emerging fungal pathogen.
Objectives: T-2307, a novel arylamidine, exhibits potent broad-spectrum activities against the majority of fungal pathogens. In this study, the antifungal activity of T-2307 against Cryptococcus gattii was evaluated in comparison with those of amphotericin B, fluconazole and voriconazole in vitro an...
| Published in: | Journal of Antimicrobial Chemotherapy (JAC) Vol. 72; no. 6; pp. 1709 - 1714 |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , |
| Format: | pictorial research tables/charts Journal Article |
| Published: |
Oxford University Press / USA
Jun2017
|
| Online Access: | View this record in EBSCOhost |